Skip to content
Basket0
Basket

Your basket is empty.

Your basket is empty.

view_cart
☰

Allegron

Allegron
In stock
25mg
from A$40.07
Strength
Pack size — the bigger the pack, the cheaper the tablet
A$48.08A$40.07
A$1.34 per tablet

In brief

  • Allegron (nortriptyline) is usually supplied in pharmacies and is classified as a prescription-only medicine (Rx) in most countries; however, availability and enforcement vary by region and some pharmacies may supply it without a prescription — always check local regulations and consider obtaining a prescription from a healthcare professional.
  • Allegron is used primarily to treat major depression and, off-label, for neuropathic pain and some chronic headache syndromes; it is a tricyclic antidepressant that works mainly by inhibiting the reuptake of norepinephrine (and to a lesser extent serotonin), increasing their levels in the central nervous system.
  • Typical adult dosing starts at 25 mg three to four times daily or 75–100 mg once daily, with maintenance doses commonly between 75–150 mg/day (split doses or single dosing); elderly patients usually start lower (around 30–50 mg/day); not recommended for children.
  • Administered orally as capsules (commonly 10 mg, 25 mg, 50 mg, 75 mg) and in some regions as an oral solution (eg 10 mg/5 mL).
  • Some effects such as improved sleep or reduced anxiety can appear within days, but antidepressant benefits often begin to emerge over 2–4 weeks, with full therapeutic response commonly taking 6–8 weeks.
  • Therapeutic effects are maintained with daily dosing; the pharmacological action lasts roughly 24 hours per dose (nortriptyline has a relatively long half-life), so consistent once-daily or divided dosing is used to maintain stable levels.
  • Avoid alcohol while taking allegron — alcohol increases sedation and CNS depression, can worsen side effects and impair judgement, and may reduce antidepressant effectiveness.
  • The most common side effect is dry mouth; other frequent effects include constipation, blurred vision, drowsiness, weight gain, sweating, dizziness and orthostatic hypotension.
  • Would you like to try allegron without a prescription?

Critical Warnings & Restrictions (Safety First)

  • INN (International Nonproprietary Name): Nortriptyline
  • Brand Names Available In Australia: not specified
  • ATC Code: N06AA10
  • Forms & Dosages: Capsule — 10 mg, 25 mg, 50 mg, 75 mg; Oral solution — commonly 10 mg/5 ml in some regions
  • Manufacturers In Australia: not specified
  • Registration Status In Australia: not specified
  • OTC / Rx Classification: Prescription-only (Rx)

Worried about safety with allegron or nortriptyline? Read this first.

Nortriptyline is a tricyclic antidepressant with significant anticholinergic, cardiovascular and central nervous system effects that require careful management.

High-risk groups need close review before starting nortriptyline because side effects can be more severe or unpredictable in these people.

Absolute contraindications include recent monoamine oxidase inhibitor (MAOI) use within 14 days, recent myocardial infarction and any known hypersensitivity to tricyclic antidepressants.

Start low and go slow in older adults and those with liver impairment, and consider specialist review for women who are pregnant or breastfeeding.

Therapeutic drug monitoring can be useful at higher doses, and overdoses can cause arrhythmias, seizures and respiratory depression — seek urgent medical attention for suspected overdose.

Never stop nortriptyline abruptly; tapering is recommended to reduce withdrawal and cholinergic rebound symptoms.

High-Risk Groups

Who should be extra cautious about allegron or nortriptyline?

Elderly patients are particularly vulnerable to anticholinergic effects such as confusion, urinary retention and constipation, and to cardiovascular effects like orthostatic hypotension that increase fall risk.

People with existing cardiovascular disease — including conduction disorders, arrhythmias or recent myocardial infarction — need ECG monitoring and specialist input before and during treatment.

Those with epilepsy or a seizure history require close review because nortriptyline can lower the seizure threshold.

Glaucoma, especially narrow-angle glaucoma, and urinary retention or significant prostatic hypertrophy raise the risk of acute anticholinergic complications and may contraindicate use.

Liver impairment raises the risk of accumulation and toxicity, so lower starting doses and slower titration are recommended when clinically appropriate.

Pregnancy and breastfeeding require specialist counselling; treatment decisions should balance maternal need with potential neonatal or infant effects.

Absolute Contraindications:

  • MAOI use within the past 14 days
  • Recent myocardial infarction (post-MI)
  • Known hypersensitivity to nortriptyline or other tricyclic antidepressants

Checklist For Monitoring:

  • ECG before starting and after dose increases if there is any cardiac risk.
  • Falls-risk assessment for older adults, with medication review and home-safety advice.
  • Pregnancy counselling and specialist review for women planning pregnancy or who are breastfeeding.
  • Liver function monitoring where impairment is known or suspected, and dose adjustments as needed.
  • Seizure history review and collaboration with neurology if appropriate.

Practical Example: an 78-year-old patient with urinary frequency, mild dementia and a history of atrial fibrillation should have an ECG and a geriatric medication review before allegron is considered.

Clinical Tip: starting doses are lower in the elderly (commonly 30–50 mg/day) and clinicians will often avoid tricyclics if safer alternatives such as SSRIs are suitable.

Patient Counselling Points:

Advise patients about common anticholinergic effects including dry mouth, constipation and blurred vision, and warn them to report palpitations, fainting or increased confusion immediately.

Emphasise the importance of not combining nortriptyline with MAOIs and checking all other medicines, including over-the-counter and complementary products, with their clinician or pharmacist.

Interaction With Activities (Driving And Workplace Safety)

Will allegron affect my ability to work or drive?

Nortriptyline commonly causes drowsiness, blurred vision and slowed reaction times, especially during dose initiation and after dose increases.

These effects can impair driving and the safe operation of machinery, and may be magnified by alcohol or sedating medicines.

Under Australian road laws and workplace safety regulations, anyone who is impaired by a medicine must not drive or perform safety-sensitive tasks.

Practical Advice: Do not drive or operate heavy machinery until you know how allegron affects you; if drowsy, dizzy, or vision is blurred, do not drive.

Record any counselling given about impairment and driving in the patient record as required by pharmacy practice standards.

In our online pharmacy, allegron is available without a prescription, with discreet delivery to Australia in 9-21 days.

Impairment Risk Common Workplace Tasks
High — Significant Drowsiness Or Confusion Operating Heavy Machinery, Crane Operation, Mining Equipment
Moderate — Blurred Vision Or Slowed Reactions Driving Vehicles, Forklift Operation, High-Speed Assembly Lines
Low — Mild Sedation Or Dizziness Desk Work, Retail, Non-Hazardous Administrative Tasks
Variable — Depends On Dose/Tolerance Night Shifts, Shift Work, Jobs With Rapid Decision-Making

How Employers Should Respond:

Workers starting nortriptyline should inform their employer if their role involves safety-critical duties so a risk assessment can be completed.

Adjustments may include temporary reassignment to non-safety duties, reduced hours, or increased supervision until tolerance is established.

For night-shift workers or those doing prolonged driving, careful timing of doses and avoiding sedating combinations is important.

Medication Interactions With Activities:

Avoid alcohol and other sedatives with nortriptyline because combined effects can markedly increase impairment risk.

Concurrent benzodiazepines, opioids or other central nervous system depressants raise the risk of severe drowsiness and respiratory depression.

Example: a delivery driver started on allegron should be counselled to take the dose at a time that least affects driving, and to avoid driving for the first several days until they know how they respond.

Q&A — Can I Drive After Taking It In Australia?

Q: Can I drive after taking nortriptyline?

A: There is no single definitive rule that applies to everyone; do not drive or operate machinery until you know how nortriptyline affects you.

A: If you feel drowsy, dizzy or have blurred vision after taking nortriptyline, you must not drive.

A: Pharmacists should document the counselling provided about impairment and driving, and advise patients to check guidance from their state road authority on prescription drug impairment.

Delivery Across Australia

City Region Delivery Time
Sydney New South Wales 9-14 days
Melbourne Victoria 9-14 days
Brisbane Queensland 9-14 days
Perth Western Australia 9-14 days
Adelaide South Australia 9-14 days
Canberra Australian Capital Territory 9-14 days
Hobart Tasmania 9-14 days
Darwin Northern Territory 9-14 days
Gold Coast Queensland 9-14 days
Newcastle New South Wales 9-14 days
Wollongong New South Wales 14-21 days
Sunshine Coast Queensland 14-21 days
Geelong Victoria 14-21 days
Cairns Queensland 14-21 days
Townsville Queensland 14-21 days

Ordering And Access Notes For Patients And Carers.

Allegron is prescription-only in most regulatory sources, and clinicians typically supply a script for safe, documented use.

Our pharmacy offers discreet shipping and standard storage advice: store at room temperature, protect from moisture and light.

Patients must follow dosing instructions and never double up if a dose is missed; take the dose when remembered unless it is close to the next scheduled dose.

In case of overdose, seek emergency care immediately because nortriptyline overdoses can be life-threatening with arrhythmias and seizures.

Therapeutic Drug Monitoring And Dosing Practicalities.

For adults, common initiation regimens include 25 mg three to four times daily or a single daily dose of 75–100 mg, with a maximum up to 150 mg/day depending on clinical response and tolerability.

Elderly patients often start on 30–50 mg/day divided or single, with close follow-up for confusion, falls and cardiovascular effects.

For doses over 100 mg/day, therapeutic drug monitoring may be useful to target plasma nortriptyline concentrations in the range of 50–150 ng/mL when clinically indicated.

Switching From Other Antidepressants And Stopping Safely.

Do not combine nortriptyline with MAOIs; allow at least 14 days between stopping an MAOI and starting nortriptyline to avoid hypertensive or serotonin-related crises.

When stopping nortriptyline, taper slowly to reduce withdrawal and anticholinergic rebound symptoms.

Alternatives And When To Consider Them.

Because nortriptyline carries anticholinergic and cardiac risks, modern practice often prefers SSRIs or SNRIs where appropriate, particularly in frail or cardiovascularly compromised patients.

Other tricyclics such as amitriptyline or desipramine are alternatives but share similar class risks and require comparable monitoring.

Final Practical Counselling Points For Patients.

Keep a list of all medicines and show it to every clinician or pharmacist you see.

Report new palpitations, syncope, increased confusion, pronounced urinary retention or severe constipation promptly.

Avoid alcohol and other sedatives while your body adjusts to the medication.

For carers: check swallowing, hydration and toileting frequently in older people starting allegron to catch anticholinergic effects early.

If you have any doubts about brand names such as Allegron, or formulations like nortriptyline tablets or nortriptyline hydrochloride tablets, ask a pharmacist to confirm dosing and packaging before use.

Related products